ReachMD
Be part of the knowledge.™Episodes 1-2 of 2
- Chronic Heart Failure in Primary Care: Diagnosis, Treatment, Referral
- Still Birthday: The Role of Bereavement Doulas in Childbirth
- A CEO's Perspective on Health Insurance in a Changing Policy Environment
- Advances in Treatment of Moderate to Severe Psoriasis
- Minimally Invasive Hysteroscopic Surgery: A “Start-Up Guide” for the Office Setting
- Emerging Concepts in the Management of MS: A Focus on T and B-Cell Targeting
- A New Blood Test for Identifying IBS and the Importance of Providing Clear Answers for Patients
- Meet the Authors: Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids with the MyoSure System
- Earlier Diagnoses for MS: Tools that Make the Biggest Patient Impacts
- Rapid Eye Movement:The Gateway to New Insights in Autism?
- U.S. Preventive Services Task Force Updates Recommendations for Depression Screening in Adults
- Immuno-Oncology: Perspectives on Current Therapies & Future Developments
- The Latest Therapies for MS: Weighing Respective Benefits and Risks
- Exploring the Patient Journey: Let’s Talk About ILD and IPF
- Diagnosing Exocrine Pancreatic Insufficiency (EPI)
- Quality Management System in the ART Laboratory
- A Glimpse at Immunomodulators in MS
- You're Hired! Physician Guidelines for Contract Negotiations
- The Role of MRI Data
- Alternate LDL Measures: Outcomes Tell the Story
- Mistreated: Why We Think We’re Getting Good Health Care—And Why We’re Usually Wrong
- Technology's Ever-Changing Roles in Health Care
- Role of Fetal Fibronectin in Identifying the Risk of Preterm Labor
- Investigating Plinabulin as Immune-Modifying Therapy for Non-Small Cell Lung Cancer (NSCLC)
- Diagnosing Exocrine Pancreatic Insufficiency (EPI)
- Why is Talking about Dyspareunia with our Menopausal Patients so Painful?
- A CEO's Perspective on Health Insurance in a Changing Policy Environment
- NEDAs Role in the Treatment of MS
- Eating Disorders and Sexuality in Boys
- The Simple and Profound Health Benefits of Smiling
- Immunologic Effects on Metabolic Syndrome and MS
- Creative Collaborations in Quality Improvement Modeling
- Origins of a Women's Sexual Health Clinic: How Simple Improvements Can Transform OB/GYN Practices
- Is LDL-C a Reliable Measure in Your At-Risk Patients?
- Unlocking Chronic Lyme Disease: Myths, Truths and Practical Solutions
- The Antipsychiatry Movement
- Optimizing MS Treatment Options
- Management of the Patient With Triglycerides 200-499 mg/dl.
- Improving Patient Care through Health & Nursing Informatics
- How to Help Patients Cope With Loss of Taste and Smell
- Corticosteroid Induced Psychiatric Symptoms
- Investigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia
- Managing Depression in Adults: New Models for Primary Care Providers
- From Connecticut — A Nurse-Turned-Cardiologist's Perspective on Delivering Care
- Technology in the Classroom: Innovations in Teaching Medicine
- Panel Discussion: A Focus on Emerging Treatment Options in Non-Small Cell Lung Cancer
- Exertional Heat Stroke (EHS): Common and Unusual Case Presentations
- Diagnosing Exocrine Pancreatic Insufficiency (EPI)
- Exertional Heat Stroke (EHS): Emergency Medical Treatment Goals
- Carrier Screening in your Practice – Is it Time to Expand your View?
- Everest ER: Practicing Medicine at 17,000 Feet
- The Role of B and T Cells in MS Pathogenesis
- Are We Prepared for MACRA and the Quality Payment Program? The Survey Says . . .
- Clinical Decisions to Effectively Maximize Treatment Outcomes
- Transforming Surgical Care Management Using Data-Centered Technology
- Exploring the Patient Journey: Let’s Talk About ILD and IPF
- A New Blood Test for Identifying IBS and the Importance of Providing Clear Answers for Patients
- Diagnosing Exocrine Pancreatic Insufficiency (EPI)
- Preimplantation Genetic Diagnosis
- Toward Instantaneous Care: Real-Time Monitoring of Vital Signs
- Exertional Heat Stroke (EHS): Neurological Characteristics and Pathophysiology
- A CEO's Perspective on Health Insurance in a Changing Policy Environment
- Where We Are and Where We Are Going: Future of ART
- Role of Fetal Fibronectin in Identifying the Risk of Preterm Labor
- Implementation of Preterm Labor Assessment Toolkit, a System-wide Initiative to Improve Preterm Labor Outcomes
- Conventional Cytology and Different Liquid Base Cytology Methods: Are They All Similar in Sensitivity When Detecting Cervical Cancer?
- Spotlight On: Revolutionizing Hysteroscopic Tissue Removal Using the MyoSure® System
- Improving Patient Care through Health & Nursing Informatics
- Transforming Surgical Care Management Using Data-Centered Technology
- Establishing Partnerships to Optimize Patient Outcomes
- “Pick Your Pace” Options Under the CMS Quality Payment Program
- FAQ: MRI and the Revised McDonald Criteria
- Carrier Screening in your Practice – Is it Time to Expand your View?
- Leveraging Technology in Healthcare: A Consulting Focus
- Investigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia
- Advances in Treatment of Moderate to Severe Psoriasis
- A CEO's Perspective on Health Insurance in a Changing Policy Environment
- Still Birthday: The Role of Bereavement Doulas in Childbirth
- 5-Step Approach to Managing CVD Risk in At-Risk Patients
- Exploring the Patient Journey: Let’s Talk About ILD and IPF
- Is LDL-C a Reliable Measure in Your At-Risk Patients?
- Meet the Authors: Fertility Outcomes After Hysteroscopic Morcellation of Polyps and Fibroids with the MyoSure System
- Technology's Ever-Changing Roles in Health Care
- Mistreated: Why We Think We’re Getting Good Health Care—And Why We’re Usually Wrong
- A CEO's Perspective on Health Insurance in a Changing Policy Environment
- You're Hired! Physician Guidelines for Contract Negotiations
- Minimally Invasive Hysteroscopic Surgery: A “Start-Up Guide” for the Office Setting
- Investigating Plinabulin as Immune-Modifying Therapy for Non-Small Cell Lung Cancer (NSCLC)
- Diagnosing Exocrine Pancreatic Insufficiency (EPI)
- A Glimpse at Immunomodulators in MS
- Immuno-Oncology: Perspectives on Current Therapies & Future Developments
- The Latest Therapies for MS: Weighing Respective Benefits and Risks
- Alternate LDL Measures: Outcomes Tell the Story
- Why is Talking about Dyspareunia with our Menopausal Patients so Painful?
- Toward Instantaneous Care: Real-Time Monitoring of Vital Signs
- The Role of MRI Data
- Emerging Concepts in the Management of MS: A Focus on T and B-Cell Targeting
- NEDAs Role in the Treatment of MS
- Managing to an LDL-P Goal within Existing Therapeutic Strategies
- Improving Patient Care through Health & Nursing Informatics
- Role of Fetal Fibronectin in Identifying the Risk of Preterm Labor
You must be logged in to display playlists.